2026-09-27T10:40:53Zhttps://dspace.mit.edu/server/oai/requestoai:dspace.mit.edu:1721.1/506122022-02-01T14:45:26Zcom_1721.1_7582com_1721.1_7581col_1721.1_131023
Fiona E. Murray.
Ching, Kenny Hwee Seong
Massachusetts Institute of Technology. Technology and Policy Program.
Massachusetts Institute of Technology. Engineering Systems Division
Technology and Policy Program
2010-01-07T21:00:58Z
2010-01-07T21:00:58Z
2004
2004
http://hdl.handle.net/1721.1/50612
469082154
Thesis (S.M.)--Massachusetts Institute of Technology, Engineering Systems Division, Technology and Policy Program, 2004.
Includes bibliographical references (leaf 54).
Clusters comprise of a particular set of ingredients, which includes researchers, entrepreneurs, venture capitalists, well-trained and educated workers, and specialized professional services. The importance of each ingredient is undeniable, yet the proximity to research centers and institutions is perhaps the most critical element of success for technology clusters. This thesis focuses on the Massachusetts Institute of Technology (MIT), and examines its role in the development of the biomedical industry cluster in Cambridge, Massachusetts. However, while the important role that academic institutions play in the process of transforming science to marketable technology is acknowledged, the question of who are the actual researchers most intimately involved in this process remains unanswered. Drawing on quantitative data, we show that the majority of commercially related research work is performed by a small fraction of the researchers, and this group is heterogeneous in characteristics. Moreover, through a novel way of examining publication data, we also show that the commercial productivity of each researcher is positively related to the researcher's relative level of applied science research. Over the past two years, Singapore has been among the most aggressive of the East Asian countries in pursuing the development of its biotechnology industry. By benchmarking Singapore against MIT, we recommend that Singapore raise its level of applied science research, to improve the integration of academic research into the marketplace.
by Kenny Hwee Seong Ching.
S.M.
55 leaves
eng
Massachusetts Institute of Technology
M.I.T. theses are protected by
copyright. They may be viewed from this source for any purpose, but
reproduction or distribution in any format is prohibited without written
permission. See provided URL for inquiries about permission.
http://dspace.mit.edu/handle/1721.1/7582
Technology and Policy Program.
Building a biomedical cluster : a comparative study of MIT and Singapore
Thesis
application/pdf
Publication
unknown
unknown
<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="6711d052-799f-45d1-ab25-e95dae2f8eb5">
<Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type>
<Language>eng</Language>
<Title>Building a biomedical cluster : a comparative study of MIT and Singapore</Title>
<PublishedIn>
<Publication>
</Publication>
</PublishedIn>
<PublicationDate>2004</PublicationDate>
<Authors>
<Author>
<DisplayName>Ching, Kenny Hwee Seong</DisplayName>
<Affiliation>
<OrgUnit>
</OrgUnit>
</Affiliation>
</Author>
</Authors>
<Editors>
</Editors>
<Publishers>
<Publisher>
<DisplayName>Massachusetts Institute of Technology</DisplayName>
<OrgUnit />
</Publisher>
</Publishers>
<License>http://dspace.mit.edu/handle/1721.1/7582</License>
<Keyword>Technology and Policy Program.</Keyword>
<Abstract>Clusters comprise of a particular set of ingredients, which includes researchers, entrepreneurs, venture capitalists, well-trained and educated workers, and specialized professional services. The importance of each ingredient is undeniable, yet the proximity to research centers and institutions is perhaps the most critical element of success for technology clusters. This thesis focuses on the Massachusetts Institute of Technology (MIT), and examines its role in the development of the biomedical industry cluster in Cambridge, Massachusetts. However, while the important role that academic institutions play in the process of transforming science to marketable technology is acknowledged, the question of who are the actual researchers most intimately involved in this process remains unanswered. Drawing on quantitative data, we show that the majority of commercially related research work is performed by a small fraction of the researchers, and this group is heterogeneous in characteristics. Moreover, through a novel way of examining publication data, we also show that the commercial productivity of each researcher is positively related to the researcher's relative level of applied science research. Over the past two years, Singapore has been among the most aggressive of the East Asian countries in pursuing the development of its biotechnology industry. By benchmarking Singapore against MIT, we recommend that Singapore raise its level of applied science research, to improve the integration of academic research into the marketplace.</Abstract>
<Access xmlns="http://purl.org/coar/access_right"
>
</Access>
</Publication>